The effect of camicinal (GSK962040), a motilin agonist, on gastric emptying and glucose absorption in feed-intolerant critically ill patients: a randomized, blinded, placebo-controlled, clinical trial
Crossref DOI link: https://doi.org/10.1186/s13054-016-1420-4
Published Online: 2016-08-01
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chapman, Marianne J.
Deane, Adam M.
O’Connor, Stephanie L.
Nguyen, Nam Q.
Fraser, Robert J. L.
Richards, Duncan B.
Hacquoil, Kimberley E.
Vasist Johnson, Lakshmi S.
Barton, Matthew E.
Dukes, George E.
Funding for this research was provided by:
GlaxoSmithKline